Since 1998, our Institute for medical research has been exclusively involved with Phase II-IV treatment studies. In contrast, conventional clinics and medical practices carry out studies secondary to their activities in clinical and private practice. We are an institutional trial site (SMO) and not a CRO with a monitoring function.
Our testing centre operates on a basis that is reliable, cost-saving and conscious of quality; we adhere to the provisions of GCP-ICH.
Our specialisations (see study indications) mean that we are able to provide the highest possible numbers of patients for your studies.
We look forward to the opportunity to work with you in carrying out your studies as well.
